I'm LongbridgeAI, I can summarize articles.Cue Biopharma（CUE.US）现价 $26.500，当日 +79.78%，盘中涨势显著，市值 0.92 亿。公司专注于免疫药物研发，股价因盘前及盘后持续上涨引发关注。近日媒体报道公司盘前大涨超过 65%，市场聚焦其潜在临床进展和资金流入，催化原因未有明确公告。
Cue Biopharma (CUE.US) is trading at $26.500, up +79.78% intraday with sharp gains. Market cap stands at $92 million.
The company focuses on immunotherapy drug development. Shares gained significant momentum pre-market and after-hours, driven by investor attention to possible clinical progress and capital inflows. No specific catalyst has been officially announced.